Cargando…
Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084367/ https://www.ncbi.nlm.nih.gov/pubmed/35543118 http://dx.doi.org/10.1002/lary.30180 |
_version_ | 1785021725842341888 |
---|---|
author | Derkay, Craig S. Wikner, Emily E. Pransky, Seth Best, Simon R. Zur, Karen Sidell, Douglas R. Klein, Adam Rosen, Clark Dikkers, Frederick G. Johnson, Romaine |
author_facet | Derkay, Craig S. Wikner, Emily E. Pransky, Seth Best, Simon R. Zur, Karen Sidell, Douglas R. Klein, Adam Rosen, Clark Dikkers, Frederick G. Johnson, Romaine |
author_sort | Derkay, Craig S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10084367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100843672023-04-11 Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? Derkay, Craig S. Wikner, Emily E. Pransky, Seth Best, Simon R. Zur, Karen Sidell, Douglas R. Klein, Adam Rosen, Clark Dikkers, Frederick G. Johnson, Romaine Laryngoscope Triological Society Best Practice John Wiley & Sons, Inc. 2022-05-11 2023-01 /pmc/articles/PMC10084367/ /pubmed/35543118 http://dx.doi.org/10.1002/lary.30180 Text en © 2022 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Triological Society Best Practice Derkay, Craig S. Wikner, Emily E. Pransky, Seth Best, Simon R. Zur, Karen Sidell, Douglas R. Klein, Adam Rosen, Clark Dikkers, Frederick G. Johnson, Romaine Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? |
title | Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? |
title_full | Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? |
title_fullStr | Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? |
title_full_unstemmed | Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? |
title_short | Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? |
title_sort | systemic use of bevacizumab for recurrent respiratory papillomatosis: who, what, where, when, and why? |
topic | Triological Society Best Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084367/ https://www.ncbi.nlm.nih.gov/pubmed/35543118 http://dx.doi.org/10.1002/lary.30180 |
work_keys_str_mv | AT derkaycraigs systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT wikneremilye systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT pranskyseth systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT bestsimonr systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT zurkaren systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT sidelldouglasr systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT kleinadam systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT rosenclark systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT dikkersfrederickg systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy AT johnsonromaine systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy |